FDA Inspection 1235694 — Advalight ApS

Advalight ApS — FEI 3010683226

The FDA completed an inspection of Advalight ApS on April 11, 2024 in Ballerup. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 11, 2024
Fiscal Year
2024
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Ballerup (Denmark)

Citations

IDCFRDescription
311721 CFR 820.70(i)Software validation for automated processes
54621 CFR 820.75(a)Lack of or inadequate process validation